The metabolic state of T cells strongly influences their effector function and anti-tumor efficacy. St. Paul et al. (2021) report that Tc22, a CD8 T cell subset with potent anti-tumor activity, upregulates the pantothenate/coenzyme A (CoA) pathway and that treatment with CoA or pantothenate is sufficient to enhance tumor immunotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmet.2021.11.009 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!